107 results on '"Madge, S."'
Search Results
2. P415 Impact of parenthood on cystic fibrosis (CF) self-care and service implications
3. P313 Knowledge and experiences of fertility, contraception and sexual reproductive health among males with cystic fibrosis in the variant specific therapy era
4. EPS2.01 Recruitment via social media results in systematic differences in responses to survey-based research in cystic fibrosis; but is this always a bad thinğ
5. P416 Routes to parenthood taken by people with cystic fibrosis (pwCF) in the variant specific (VST) era
6. 597 Off-label use of CFTR modulators in the U.K. cystic fibrosis population without a F508del mutation
7. 565 Breastfeeding in cystic fibrosis: a review of nutritional and metabolic impacts
8. WS10.06 How representative are clinical trial cohorts of the general cystic fibrosis population? Implications for trial planning
9. P177 Cystic fibrosis (CF)-related complications and outcomes of women during pregnancy and post-partum in elexacaftor/tezacaftor/ivacaftor (ETI)-era
10. P178 Impact of pre-conception lung function in women with cystic fibrosis (wwCF) on obstetric and neonatal outcomes in the elexacaftor/tezacaftor/ivacaftor (ETI)-era
11. P71 Remote respiratory sampling and unusual Pseudomonas growths in adults with cystic fibrosis: Is there a link?
12. P116 A systematic review to identify and collate the patient-centred factors influencing patient journeys through clinical trials
13. P62 A discrete choice experiment (DCE) to quantify the influence of trial features on the decision to participate in Cystic Fibrosis (CF) trials
14. 89 A novel cystic fibrosis–pregnancy service: Two-year review after introduction of elexacaftor/tezacaftor/ivacaftor
15. Implementing tablet-based ototoxicity screening in adult respiratory patients
16. WS02.05 The use of elexacaftor/tezacaftor/ivacaftor in adult patients with cystic fibrosis and established liver cirrhosis: a case series
17. ePS5.06 Implementing tablet-based ototoxicity screening in adults with cystic fibrosis
18. ePS6.09 A discrete choice experiment to quantify the influence of trial features on patients’ decisions to join cystic fibrosis clinical trials
19. P046 The effectiveness of CFTR modulators in people with cystic fibrosis and rare mutations – a real-world study
20. P156 Patterns of liver dysfunction and the development of a pathway for liver monitoring in adults with cystic fibrosis (CF) on elexacaftor/tezacaftor/ivacaftor (ETI): a quality improvement project
21. P201 Bowel screening for cancer in pre-transplant people with cystic fibrosis and the accuracy of faecal immunochemical testing
22. 116: Implementing a digital clinic review service in a national lockdown
23. 46: A discrete choice experiment (DCE) to quantify the influence of trial features on the decision to participate in CF trials
24. Guiding the rational design of patient-centred drug trials in Cystic Fibrosis: A Delphi study
25. P246 Transition in cystic fibrosis: international trends
26. P075 Are there lessons to be learned from cystic fibrosis patient deaths and the timing of lung transplant referral?
27. P076 Using the Cystic Fibrosis Foundation consensus guidelines to assess the timing of lung transplant referral for individuals with cystic fibrosis in a single large adult UK centre: do they help?
28. P203 Fertile ground: pregnancies in a post-Kaftrio® pandemic era
29. WS14.5 SARS-CoV-2 driving rapid change in cystic fibrosis services: the role of the clinical nurse specialist
30. P051 Rollout of Kaftrio® to adult cystic fibrosis patients at the Royal Brompton Hospital during a global pandemic
31. P057 Assessing the timing and clinical characteristics of patients with cystic fibrosis referred for a lung transplant: an observational single centre study
32. P361 What influences participation in clinical trials by people with cystic fibrosis? A national delphi study
33. ePS1.07 Patient experience of virtual consultations: survey results
34. P045 User experience of virtual consultations
35. WS05-6 Changing the culture of the cystic fibrosis multidisciplinary team to discuss preferred place of death with patients
36. P408 Patient preferences regarding lung transplant referral
37. ePS5.04 A digital solution for virtual consultation and sharing health data in adults with cystic fibrosis
38. A novel and effective ophthalmology morbidity and mortality meeting
39. WS18.3 The introduction of a cystic fibrosis-specific advance care planning document
40. Screening for intimate partner violence in a London HIV clinic: characteristics of those screening positive
41. ePS02.5 Striving to improve the outpatient journey for adults with cystic fibrosis – a quality improvement project
42. End of Life: Have we got it right?
43. CF-CATS2: Is it feasible to use web-based technology to teach Tai Chi in order to integrate it into routine medical treatment for people with cystic fibrosis?
44. Adaptation of hydrophite system for purification of wastewaters of civil aviation enterprises
45. 28 Developing a specialist nurse run adult sweat test clinic
46. The outcome of pregnancies in women with cystic fibrosis-single centre experience 1998-2011
47. 85 I-neb Insight Online – a telemedicine option in the treatment of cystic fibrosis
48. 83 I-neb Insight Online – a telemedicine-based system to monitor true adherence to nebulizer therapy in adult cystic fibrosis patients: a preliminary analysis
49. 316 Factors that increase depression in adults with cystic fibrosis
50. Development of a social inclusion index to capture subjective and objective life domains (Phase II): psychometric development study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.